Emese Kiss

Emese Kiss publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Emese Kiss sits on this spectrum.

Emese Kiss D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Emese Kiss sits on this spectrum.

Best Publications

• Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D?

  H. Amital;Z. Szekanecz;G. Szücs;K. Dankó

  389
  Citations

• Current causes of death in systemic lupus erythematosus in Europe, 2000--2004: relation to disease activity and damage accrual.

  Johannes C. Nossent;N. Cikes;E. Kiss;A. Marchesoni

  326
  Citations

• Association of systemic and thyroid autoimmune diseases.

  Edit Biró;Zoltán Szekanecz;László Czirják;Katalin Dankó

  282
  Citations

• Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD).

  Edit Bodolay;Zoltan Csiki;Zoltan Szekanecz;Thomas Ben

  205
  Citations

• Disease activity and damage accrual during the early disease course in a multinational inception cohort of patients with systemic lupus erythematosus.

  J Nossent;E Kiss;B Rozman;G Pokorny

  196
  Citations

• Heat shock protein 70 is a potent activator of the human complement system.

  Zoltán Prohászka;Mahavir Singh;Kálmán Nagy;Emese Kiss

  161
  Citations

• Anti-vitamin D, vitamin D in SLE: preliminary results.

  Jozélio Freire Carvalho;Jozélio Freire Carvalho;Miri Blank;Emese Kiss;Tunde Tarr

  155
  Citations

• Comparative assessment of vascular function in autoimmune rheumatic diseases: considerations of prevention and treatment.

  Pál Soltész;György Kerekes;Henriett Dér;Gabriella Szücs

  155
  Citations

• Cardiac manifestations in antiphospholipid syndrome

  Pál Soltész;Zoltán Szekanecz;Emese Kiss;Yehuda Shoenfeld

  147
  Citations

• Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation

  A. J. G. Swaak;H. G. van den Brink;R. J. T. Smeenk;K. Manger

  140
  Citations

• Incomplete lupus erythematosus: results of a multicentre study under the supervision of the EULAR Standing Committee on International Clinical Studies Including Therapeutic Trials (ESCISIT)

  A. J. G. Swaak;H. van de Brink;R. J. T. Smeenk;K. Manger

  133
  Citations

• Dyslipidemia in systemic lupus erythematosus

  Melinda Zsuzsanna Szabó;Peter Szodoray;Emese Kiss

  131
  Citations

• Isotype distribution and clinical relevance of anti‐β2‐glycoprotein I (β2‐GPI) antibodies: importance of IgA isotype

  Gabriella Lakos;E. Kiss;N. Regéczy;P. Tarján

  121
  Citations

• Malignancies in systemic lupus erythematosus

  Emese Kiss;Laszlo Kovacs;Peter Szodoray

  112
  Citations

• Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients

  T. Tarr;G. Lakos;H. P. Bhattoa;Y. Shoenfeld

  112
  Citations

• The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary.

  P Szodoray;T Tarr;A Bazso;G Poor

  110
  Citations

• Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients.

  Emese Kiss;Pal Soltesz;Henrietta Der;Zsolt Kocsis

  109
  Citations

• Malignancies and soluble tumor antigens in rheumatic diseases.

  Éva Szekanecz;Csilla András;Zsuzsa Sándor;Péter Antal-Szalmás

  108
  Citations

• Evaluation of clinical and laboratory features of antiphospholipid syndrome: a retrospective study of 637 patients.

  P Soltész;K Veres;G Lakos;E Kiss

  108
  Citations

• Antibodies against human heat-shock protein (hsp) 60 and mycobacterial hsp65 differ in their antigen specificity and complement-activating ability

  Zoltán Prohászka;Jenõ Duba;Gabriella Lakos;Emese Kiss

  102
  Citations

• Measurement of natural (CD4+CD25high) and inducible (CD4+IL-10+) regulatory T cells in patients with systemic lupus erythematosus:

  S. Barath;M. Aleksza;T. Tarr;S. Sipka

  92
  Citations

• Systemic lupus erythematosus. Disease outcome in patients with a disease duration of at least 10 years: second evaluation.

  Ajg J.G. Swaak;H. G. Van Den Brink;Rjt J.T. Smeenk;K. Manger

  86
  Citations

• Significant correlation between the CD63 assay and the histamine release assay in chronic urticaria

  A. Szegedi;B. Irinyi;M. Gál;J. Hunyadi

  85
  Citations